3 ms·
Australia is just getting started developing a investor ecosystem. In the last few years there are a few entrepreneurs like me that have have started giving bac
by danieltillett 9y ago
Australia is just getting started developing a investor ecosystem. In the last few years there are a few entrepreneurs like me that have have started giving back to build the ecosystem, but relatively few.
The real blocking point is Series B and beyond where there is very little true VC money. Biotechs really need support at this stage and it forces far too many Australian biotechs to list on the ASX at a very early stage.
- aaavl2821 9y agoAre there many therapeutics startups in Australia? I remember seeing a decent amount of diagnostics / device pitches from australian companies (or device firms that listed on ASX) but don't remember seeing many drug developers (not that I have a large sample size to draw from). If there are interesting therapeutics startups in Australia I am sure that US biotech VCs would take a look, as there is a bit of a crowded series a market here (lots of VC money but not many good seed-stage startups) and many VCs are looking to europe for science or startups
- danieltillett 9y agoThere are a few, but not many. You will find it a lot easier to pitch a diagnostic or device startup than a tradition therapeutic startup. I think the major killer here is the distance - Australia is just so far from anywhere other than NZ.